Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials.

Creators: Mercuri, E; Finkel, R; Montes, J; Mazzone, Es; SORMANI, MARIA PIA; Main, M; Ramsey, D; Mayhew, A; Glanzman, Am; Dunaway, S; Salazar, R; Pasternak, A; Quigley, J; Pane, M; Pera, Mc; Scoto, M; Messina, S; Sframeli, M; Vita, Gl; D'Amico, A; van den Hauwe, M; Sivo, S; Goemans, N; Kaufmann, P; Darras, Bt; Bertini, E; Muntoni, F; De Vivo, D.c.3.

Others:: Mercuri, E; Finkel, R; Montes, J; Mazzone, E; Sormani, MARIA PIA; Main, M; Ramsey, D; Mayhew, A; Glanzman, Am; Dunaway, S; Salazar, R; Pasternak, A; Quigley, J; Pane, M; Pera, Mc; Scoto, M; Messina, S; Sframeli, M; Vita, Gl; D'Amico, A; van den Hauwe, M; Sivo, S; Goemans, N; Kaufmann, P; Darras, Bt; Bertini, E; Muntoni, F; De Vivo, D. c. 3.

Additional details